Literature DB >> 11508586

Comparison of extracapsular changes by magnetic resonance imaging in patients with rheumatoid arthritis and polymyalgia rheumatica.

D McGonagle1, C Pease, H Marzo-Ortega, P O'Connor, W Gibbon, P Emery.   

Abstract

OBJECTIVE: Joint inflammation in polymyalgia rheumatica is regarded primarily as a disease of the synovial cavities and bursae, but the adjacent capsules and soft tissues have not been evaluated using sensitive imaging methods. We used fat suppression magnetic resonance imaging (MRI) to determine anatomical sites of inflammatory change in the shoulders of patients with early polymyalgia rheumatica (PMR) and a control group of patients with rheumatoid arthritis (RA).
METHODS: Fourteen patients with PMR and 14 with RA (a total of 20 shoulders in each group) were evaluated. T2 SPIR (fat suppressed) coronal oblique MRI sequences of the shoulders were performed. Scans were assessed for sites of joint effusion, bursitis, tenosynovitis, bone edema, and extracapsular soft tissue edema. Statistical analysis was performed using Fisher's test.
RESULTS: Nine of 14 patients (10/20 joints) with PMR but only 2/14 (2/20 joints) with RA had prominent edema at extracapsular sites adjacent to the joint capsule or in the soft tissues (p = 0.02). Both groups had a comparable degree of joint effusion (18 PMR, 17 RA), bursitis (18 PMR, 16 RA), and tenosynovitis (3 PMR, 2 RA).
CONCLUSION: The only significant difference between the 2 groups was the presence of inflammatory change outside the joint cavity in patients with PMR. This may contribute to the diffuse nature of symptoms in PMR and have implications for its pathogenesis.

Entities:  

Mesh:

Year:  2001        PMID: 11508586

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  14 in total

Review 1.  [Polymyalgia rheumatica: myalgic syndrome or occult vasculitis?].

Authors:  B Hellmich; W L Gross
Journal:  Internist (Berl)       Date:  2005-11       Impact factor: 0.743

Review 2.  Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.

Authors:  Jean Schmidt; Kenneth J Warrington
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

Review 3.  The role of imaging in polymyalgia rheumatica/giant cell arteritis.

Authors:  William S Wilke
Journal:  Skeletal Radiol       Date:  2008-09       Impact factor: 2.199

Review 4.  Advances and challenges in the diagnosis and treatment of polymyalgia rheumatica.

Authors:  Tanaz A Kermani; Kenneth J Warrington
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-02       Impact factor: 5.346

Review 5.  [Skeletal changes due to bone metastases : Morphology and selected differential diagnoses].

Authors:  J Wiens
Journal:  Radiologe       Date:  2021-10-28       Impact factor: 0.635

Review 6.  MRI in psoriatic arthritis: insights into pathogenesis and treatment response.

Authors:  Fiona M McQueen; Nicola Dalbeth; Anthony Doyle
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

Review 7.  Pathogenesis, Diagnosis and Management of Polymyalgia Rheumatica.

Authors:  Dario Camellino; Andrea Giusti; Giuseppe Girasole; Gerolamo Bianchi; Christian Dejaco
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

Review 8.  Magnetic resonance imaging: opportunities for rheumatoid arthritis disease assessment and monitoring long-term treatment outcomes.

Authors:  Paul Emery
Journal:  Arthritis Res       Date:  2002-04-18

Review 9.  What magnetic resonance imaging has told us about the pathogenesis of rheumatoid arthritis--the first 50 years.

Authors:  Dennis McGonagle; Ai Lyn Tan
Journal:  Arthritis Res Ther       Date:  2008-10-10       Impact factor: 5.156

10.  Accuracy of musculoskeletal imaging for the diagnosis of polymyalgia rheumatica: systematic review.

Authors:  Sarah Louise Mackie; Gouri Koduri; Catherine L Hill; Richard J Wakefield; Andrew Hutchings; Clement Loy; Bhaskar Dasgupta; Jeremy C Wyatt
Journal:  RMD Open       Date:  2015-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.